BRISTOL-MYERS SQUIBB COMPANY Variable Lease, Cost
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Variable Lease, Cost of $90.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-11
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for the quarter ending 2019-12-31 was $10.00M.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for the quarter ending 2019-09-30 was $5.00M.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for the quarter ending 2019-06-30 was $4.00M.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for the quarter ending 2019-03-31 was $6.00M.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for fiscal 2025 was $90.00M, a 21.62% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for fiscal 2024 was $74.00M, a 6.33% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for fiscal 2023 was $79.00M, a 43.64% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY variable lease, cost for fiscal 2022 was $55.00M, a 25.00% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $90.00M 10-K · filed 2026-02-11 | |||
| 2024-12-31 | $74.00M 10-K · filed 2026-02-11 | |||
| 2023-12-31 | $79.00M 10-K · filed 2026-02-11 | |||
| 2022-12-31 | $55.00M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $44.00M 10-K · filed 2024-02-13 | |||
| 2020-12-31 | $50.00M 10-K · filed 2023-02-14 | |||
| 2019-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $15.00M derived: sum of 2 quarters · filed 2022-02-09 | $19.00M derived: sum of 3 quarters · filed 2022-02-09 | $25.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $5.00M 10-Q · filed 2019-10-31 | $9.00M derived: sum of 2 quarters · filed 2019-10-31 | $15.00M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $4.00M 10-Q · filed 2019-07-25 | $10.00M 10-Q · filed 2019-07-25 | ||
| 2019-03-31 | $6.00M 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |